Colorectal Cancer Clinical Trials in Raleigh, NC

Colorectal Cancer Clinical Trials in Raleigh, NC

View the best 10 colorectal cancer medical studies in Raleigh, North Carolina. Access promising new therapies by applying to a Raleigh-based Colorectal Cancer clinical trial.

Trials in Raleigh, North Carolina

Here are the top 10 medical studies for colorectal cancer in Raleigh, North Carolina

Image of GSK Investigational Site in Tucson, United States.

Dostarlimab +2 More

PD-1 Inhibitor

Recruiting2 awardsPhase 3
This trial is testing dostarlimab, a drug that helps the immune system fight cancer. It targets patients with a specific type of colon cancer that has certain genetic features and can be surgically removed. Dostarlimab works by helping the immune system recognize and destroy cancer cells.
Image of Apollo Investigative Site in Duarte, United States.

APL-5125

Anti-tumor antibiotic

Recruiting1 awardPhase 1 & 2
This trial will test the safety, side effects, and effectiveness of a drug called APL-5125 for treating advanced solid tumors, specifically focusing on colorectal cancer.
Image of Mayo Clinic of Scottsdale in Scottsdale, United States.

LOXO-292

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug called selpercatinib in patients with advanced cancers that have specific gene changes. The drug aims to block a gene that helps cancer grow, potentially slowing or stopping the disease.
Image of Site 1030 South Texas Accelerated Research Therapeutics (START) Midwest in Grand Rapids, United States.

BDTX-4933

Recruiting1 awardPhase 1
This trial studies a new oral medicine to treat certain advanced and metastatic cancers in adults. It looks at how safe and effective the medicine is.
Image of USOR - Virginia Cancer Specialists - Fairfax Office in Fairfax, United States.

BGB-3245 +1 More

Kinase Inhibitor

Recruiting1 awardPhase 1
"This trial aims to assess the safety and effectiveness of a combination of BGB-3245 and panitumumab in patients with advanced colorectal cancer. The study will determine the maximum tolerated dose
Image of Sarah Cannon Research Institute - CO in Denver, United States.

ST316

WNT/β-catenin signaling pathway inhibitor

Recruiting1 awardPhase 1
This trial tests a new cancer drug to find if it's safe, how it works, and if it's effective against advanced solid tumors.
Image of USC Norris Comprehensive Cancer Center in Los Angeles, United States.

PC14586 +1 More

Small Molecule

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Image of SWOG in Portland, United States.

Cetuximab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing whether adding nivolumab to the usual treatment of encorafenib and cetuximab works better at shrinking tumors in patients with colorectal cancer that has spread or cannot be removed by surgery.
Image of City of Hope National Medical Center in Duarte, United States.

Sotorasib +1 More

Small Molecule Drug

Recruiting2 awardsPhase 3
This trial is testing two doses of sotorasib combined with panitumumab in patients with a specific type of colorectal cancer that has not responded to other treatments. Sotorasib targets a genetic mutation in the cancer cells, while panitumumab helps the immune system attack the cancer. The goal is to see if this combination can help patients live longer without their cancer getting worse.
Image of Virginia Commonwealth University Massey Cancer Center in Richmond, United States.

mFOLFOX +1 More

Anti-metabolites

Recruiting1 awardPhase 2
This trial is testing a new way to treat rectal cancer that may be less intense and have fewer side effects.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.